Get started

Chart Patterns

#IDBI - VCP BO in WTFScript: IDBI Key highlights: 💡⚡ 📈 VCP BO in WTF 📈 Volume spike seen during Breakout 📈 MACD Bounce 📈 RS Line making 52WH 📈 Sector is strong If you have any doubts about the setup, drop a comment and I’ll reply. ✅Boost and follow to never miss a new idea! ✅ ⚠️ Important: Always Exit the trade before any Event. ⚠️ Important: Always maintain your Risk:Reward Ratio as 1:2, with this RR, you only need a 33% win rate to Breakeven. ⚠️Disclaimer: I am not SEBI Registered Advisor. My posts are purely for training and educational purposes. Eat🍜 Sleep😴 TradingView📈 Repeat 🔁
NSE:IDBILong
by MMT_MakeMoneyTrading
BTC PredictionI’ll analyze what your BTCUSD (Daily) chart is showing and what to expect next, based strictly on the structure you marked (A-B-C-D + wedge/triangle). 🔍 What the chart is telling 1️⃣ Market structure Strong downtrend from ~115k → 90k (below 50 & 200 EMA). Price is now consolidating inside a descending / contracting triangle (wedge). You’ve marked a harmonic-like ABCD corrective structure after the impulse drop. This is not accumulation yet — it’s a bearish continuation setup unless proven otherwise. 2️⃣ EMA & Trend context Price below 50 EMA (yellow) & 200 EMA (black) → bearish bias EMAs are sloping down, acting as dynamic resistance Repeated rejection near 92k–93k zone ➡️ Trend is still DOWN. 3️⃣ Triangle / Wedge interpretation Lower highs + slightly higher lows Volume contraction (implied) This pattern usually resolves in the direction of the prior trend 📌 Prior trend = DOWN, so breakdown probability is higher 🎯 Key Levels to Watch Resistance (very important) 92,800 – 93,200 → strong supply + EMA resistance 99,900 – 100,000 → major trendline resistance (unlikely without breakout) Support 90,500 – 91,000 → current support (make-or-break zone) 85,000 78,000 – 76,000 71,600 (major weekly support) 📉 Most Probable Scenarios 🔴 Scenario 1: Bearish Breakdown (HIGH probability) If daily candle closes below 90,500: Target 1: 85,000 Target 2: 78,000 Target 3: 71,600 This matches your green downside projection box ✔️ 🟢 Scenario 2: Bullish Invalidity (LOW probability) Only if: Daily close above 93,500 Then reclaim 95,000 And finally break 100,000 with volume Until then → all upside is just a pullback 🧠 Smart Trading Advice (very important) ❌ Avoid long positions inside the triangle ✅ Trade breakout or breakdown only For investors: wait near 78k–72k zone for accumulation Risk is still high 🧾 Summary Structure: Bearish continuation Pattern: Descending triangle / corrective ABCD Bias: Down Expectation: Breakdown before any major rally
BITSTAMP:BTCUSDShort
by peddollakishore
2
IDBI BANK LTD ANALYSISTHIS IS MY CHART OF THE WEEK PICK FOR LEARNING PURPOSE IDBI BANK- The current price of IDBI is 114.73 rupees I am going to buy this stock because of the reasons as follows- 1. It has given a breakout of last 11 year resistance with some good volume and looks great. 2. This stock has seen some great buying from mid 2022 to March 2024. Then it went for some time and price correction which was needed. This stock has been in my watchlist from last weeks. I am personally more aggressive on Banks as they are holding really well. 3. It is showing better relative strength as it stood strong in volatile times including last few weeks. 4. The risk and reward is favourable. 5. The stock is one of the outperformers in this market. The structure is great as of now. It has also outperformed it's sector in very short term but it was more of a lagging stock in long term and probably it will show better strength in coming days. 6. Another good part- The overall sector has shown some decent strength and have good momentum. I am expecting more from this in coming weeks. I will buy it with minimum target of 35-40% and then will trail after that. My SL is at 100 rupees. I will be managing my risk.
NSE:IDBILong
by Its_Bhushan
2026 XAUUSD/GOLD YEARLY ANALYSISXAUUSD / GOLD – 2026 Yearly Buy Plan With Entry, Stop Loss & Targets 🔹 Market Bias Gold (XAUUSD) is bullish for 2026 based on: Global economic uncertainty Central bank gold accumulation Expected US interest-rate cuts Strong long-term bullish structure on the daily chart 🔹 Buy Zones (Entries) ✅ Major Buy Zone (Best Risk–Reward) Entry: 3,250 – 3,300 This zone is near: Golden Fibonacci retracement Yearly swing low Strong institutional demand area 👉 Suitable for positional & long-term investors ✅ First Confirmation Buy Entry: 3,950 – 4,050 Buy only if price holds above support and shows bullish candles 👉 Suitable for safe swing traders 🔴 Stop Loss (Risk Control) 🛑 Stop Loss Placement Stop Loss: Below 3,150 Reason: Break of yearly structure Bullish view invalid below this level 📌 Risk should be 1–2% per trade, not more. 🎯 Take Profit Targets (2026) 🎯 Target 1 4,800 – 5,000 Partial profit booking recommended (30–40%) 🎯 Target 2 5,800 – 6,000 Trail stop loss to cost or profit 🎯 Target 3 (Long-Term Extreme Target) 7,500 – 7,800 Only for patient positional holders 🔹 Trade Management Plan Buy only on pullbacks, not at highs Book partial profits at each target Move stop loss gradually as price moves up Avoid over-leverage
OANDA:XAUUSDLong
by kripsonfx97
Force Motors Ltd - Breakout Setup, Move is ON...#FORCEMOT trading above Resistance of 21123 Next Resistance is at 30646 Support is at 14435 Here are previous charts: Chart is self explanatory. Levels of breakout, possible up-moves (where stock may find resistances) and support (close below which, setup will be invalidated) are clearly defined. Disclaimer: This is for demonstration and educational purpose only. This is not buying or selling recommendations. I am not SEBI registered. Please consult your financial advisor before taking any trade.
NSE:FORCEMOTLong
by MandeepSinghKohli
Laurus Labs Limited - Breakout Setup, Move is ON...#LAURUSLABS trading above Resistance of 1091 Next Resistance is at 1512 Support is at 806 Here are previous charts: Chart is self explanatory. Levels of breakout, possible up-moves (where stock may find resistances) and support (close below which, setup will be invalidated) are clearly defined. Disclaimer: This is for demonstration and educational purpose only. This is not buying or selling recommendations. I am not SEBI registered. Please consult your financial advisor before taking any trade.
NSE:LAURUSLABSLong
by MandeepSinghKohli
Market View: Strong Uptrend Confirmation for Indian MarketMarket View: Strong Uptrend Confirmation for Indian Market Key Condition for a Sustainable Rally For a high-confidence and low-failure bullish phase in the Indian stock market, both of the following must hold: NIFTY 50 sustains above its All-Time High RELIANCE sustains above its All-Time High > These two act as the backbone of the Indian indices. When they move together, the probability of a broad-based rally increases significantly. Why NIFTY + RELIANCE Together Matter NIFTY represents overall market sentiment and institutional positioning RELIANCE carries heavy index weight and reflects FII + DII conviction When both are above ATH: Distribution risk reduces Pullbacks turn into buying opportunities Trend failures become rare Impact on Small-Cap & Mid-Cap Stocks Once NIFTY and RELIANCE confirm strength: Liquidity flows down the market cap ladder Small-caps and mid-caps outperform Sector rotation accelerates Stocks start moving toward their own All-Time Highs Breakout + momentum strategies work exceptionally well > Historically, real wealth-creating phases begin only after large-cap leadership confirms. Trading Strategy (Action Plan) Prefer buy on dips, not shorting Focus on: Stocks near 52-week high / ATH Strong relative strength vs NIFTY Volume expansion on breakouts Avoid counter-trend shorts in mid & small caps Risk Note If either NIFTY or RELIANCE fails to sustain above ATH, market may: Turn sideways Enter selective stock-specific moves See false breakouts in small caps > NIFTY + RELIANCE above All-Time High = Green signal for Indian Market. This combination unlocks powerful momentum in small-cap and mid-cap stocks, pushing the broader market toward new highs.
NSE:NIFTYLong
by Chart_Code
$XRP Price Forecast | Is $10 Possible?CRYPTOCAP:XRP Is Currently Retesting A Breakout That Took Nearly 8 Years To Form — A Rare, High-Timeframe, Cycle-Level Structure That Typically Precedes Major Market Expansions. The Last Time This Exact Structure Appeared (2017), XRP Delivered An Extraordinary 40,000% (400x) Move Following The Breakout. Current High-Timeframe Technical Structure: ✅ Multi-Year Descending Structure Broken ✅ ~57% Corrective Pullback From Recent ATH ✅ Price Holding Within The $2–$1.50 Demand Zone ✅ Strong Macro Support Identified At $1–$0.80 As Long As Price Respects This Support Region, The Primary Technical Projection Remains $8–$10 XRP Over The Cycle, Based On Measured Move And Historical Structure Behavior. Why Expect Only 5x–10x From Here? The Previous Multi-Year XRP Breakout Resulted In A 400x (40,000%) Expansion. Historically, Large Bases Lead To Large Moves — Not Modest Returns. From A Purely Structural Perspective, A Move Toward $10–$20 Cannot Be Ruled Out In The Next Market Cycle If The Breakout Holds And Momentum Confirms. Disclaimer: This Analysis Is For Educational Purposes Only And Does Not Constitute Financial Advice. Technical Analysis Is Probabilistic, Not Predictive. Always Apply Proper Risk Management And Conduct Your Own Research.
BITSTAMP:XRPUSDLong
by CryptoPatel
ENTERO: Trendline Breakout From IPO Base, Chart of The WeekFrom IPO Euphoria to Reality Check: Is Entero Healthcare Finding Its Footing at ₹1,000? Last Week, it broke the Trendline after Taking Support on the IPO base. Let's Understand in "Chart of the Week" As per the Latest SEBI Mandate, this isn't a Trading/Investment RECOMMENDATION nor for Educational Purposes; it is just for Informational purposes only. The chart data used is 3 Months old, as Showing Live Chart Data is not allowed according to the New SEBI Mandate. Disclaimer: "I am not a SEBI REGISTERED RESEARCH ANALYST AND INVESTMENT ADVISER." This analysis is intended solely for informational purposes and should not be interpreted as financial advice. It is advisable to consult a qualified financial advisor or conduct thorough research before making investment decisions. Price Action Analysis: Overall Trend Structure: The stock exhibits a classic post-IPO distribution pattern that has transitioned into a prolonged corrective phase. After listing at premium levels, Entero Healthcare established an all-time high of around ₹1,584 in the early trading sessions. Since then, the stock has been in a consistent downtrend, forming a descending channel pattern characterised by lower highs and lower lows. The current price action at ₹1,123 represents a potential inflexion point, with the stock attempting to reverse from its 52-week low of ₹944. This level has now been tested multiple times, suggesting it may be forming a demand zone. Base Formation and Consolidation Zones: A Critical IPO base zone around the ₹950-1,000 level represents the convergence of several technical factors: - Initial Public Offering pricing memory - Multiple tests of support over several weeks - High volume accumulation zone - Psychological round number support at ₹1,000 The stock spent considerable time between ₹1,100-1,300 during the mid-2025 period, forming what appears to be a distribution zone where early investors and IPO allocates likely exited positions. Trendline Analysis: A prominent downtrend line connects the series of lower highs from the peak at ₹1,584 down to current levels. This trendline has acted as dynamic resistance throughout the decline, with multiple failed breakout attempts. The angle of decline suggests aggressive selling pressure that has only recently started to moderate. The recent price action shows the stock attempting to break above this multi-week downtrend line, which, if successful on sustained volume, could signal a trend reversal. Current Price Structure: Recent candlestick patterns show increasing buying pressure: - Strong bullish candle with 17.95% gain, breaking above recent consolidation - Price attempting to reclaim the ₹1,100-1,200 zone - Reduction in selling pressure as evidenced by smaller-bodied bearish candles in recent sessions Volume Spread Analysis: Volume Profile: The volume bar chart at the bottom reveals several critical insights: Initial listing period showed extremely high volumes (approaching 3M shares), reflecting IPO excitement and allocation distribution. As the stock price declined, volume generally decreased, which is typical of a loss of interest and momentum. Recent sessions have shown a notable pickup in volume, particularly: - The current session is showing 2.17M shares traded - This represents the highest weekly volume since the post-IPO period - Volume spike coinciding with price bounce from the ₹944 low Volume-Price Correlation: The relationship between price and volume provides important context: - Downtrend was accompanied by declining volume, suggesting weak conviction in the selling - Recent bounce from ₹944 came with significant volume expansion, indicating institutional or informed buying - The volume surge at support levels suggests accumulation rather than distribution - Volume on up days is starting to exceed volume on down days, a positive divergence Volume at Key Levels: The IPO base around ₹1,000 has seen sustained high volume, creating a significant support zone. This volume cluster suggests that many participants have established positions at these levels and are likely to defend them. Key Support and Resistance: Major Support Levels: Primary Support: ₹944 - This represents the 52-week low and has been tested multiple times. A breakdown below this level would be technically significant and likely trigger stop losses. Secondary Support : ₹1,000 (IPO Base) - This psychological level and IPO reference point have provided support during multiple retests. Tertiary Support: ₹1,100 - This level has acted as both support and resistance during the consolidation phase and represents a minor demand zone. Major Resistance Levels: Immediate Resistance: ₹1,200 - This level represents the recent consolidation zone ceiling and the lower boundary of the prior distribution range. Primary Resistance: ₹1,300 - Strong resistance zone where the stock has repeatedly failed to sustain higher prices. This area coincides with multiple supply zones from earlier in the year. Major Resistance: ₹1,400 - The upper boundary of the post-IPO distribution range. Breaking above this would negate the bearish structure. Ultimate Resistance: ₹1,584 (All-Time High) - The peak was established shortly after IPO listing. A move to this level would represent a full recovery. Downtrend Line Resistance: The descending trendline connecting the highs currently intersects around the ₹1,150-1,200 zone. This dynamic resistance will need to be convincingly broken for the downtrend to be considered over. The current price action suggests this breakout may be in progress. Major Technical Patterns: Falling Wedge (Potential): In the most recent price action, there are early signs of a falling wedge pattern forming, characterised by converging trendlines as the stock makes lower lows with decreasing momentum. This is typically a bullish reversal pattern. Double Bottom (Forming): The chart shows a potential double bottom pattern with lows around ₹944 separated by several weeks. This pattern would be confirmed on a break above ₹1,200 with volume. Candlestick Patterns: Recent price action displays several notable candlestick formations: - Hammer candles at the ₹944 support level, indicating rejection of lower prices - Doji candles during consolidation phases, showing indecision - Today's strong bullish engulfing pattern suggests a momentum shift - Decreasing size of bearish candles in the downtrend, showing exhaustion Chart Pattern Implications: The combination of these patterns suggests: - Downtrend may be exhausting - Support at ₹944 is holding firm - Volume accumulation at lows indicates smart money positioning - Breaking the downtrend line could trigger technical buying - A confirmed reversal would target ₹1,300-1,400 initially Fundamental and Sectoral Backdrop: Company Overview: NSE:ENTERO operates as a leading healthcare products distributor in India, ranking among the top three in the sector. Founded in 2018 by promoter Prabhat Agrawal, the company has rapidly scaled its operations through both organic growth and strategic acquisitions. Business Model and Operations: Core Business: Distribution and marketing of pharmaceutical and surgical products, including generic formulations, surgical consumables, medical devices, nutraceuticals, biosimilars, and hospital consumables. Infrastructure: The company operates an extensive distribution network with 101 warehouses across 20 states, serving over 95,300 retail pharmacies and more than 3,600 hospitals. Growth Strategy: Aggressive expansion through acquisitions. In FY2025 alone, the company acquired stakes in seven distribution entities, including 80% stakes in Avenir Lifecare and Gourav Medical Agencies, and the full acquisition of Suprabhat Pharmaceuticals and Devi Pharma Wellness. Technology Edge: Utilises a proprietary technology platform for demand fulfilment and supply chain optimisation, positioning itself as a "Healthcare Supply Chain Solutions Specialist." Financial Performance: Revenue Growth: Demonstrated strong top-line growth with Q2 FY2025-26 showing 20.1% year-over-year growth and 11.8% quarter-on-quarter increase to ₹5,135 crores. Market Capitalization: Currently around ₹4,888 crores Profitability Journey: The company was loss-making from FY2021-2023 but turned profitable in FY2024. For the full year FY2025-2026, profit reached ₹107.43 crores, marking a significant turnaround. Institutional Interest: Recent institutional activity indicates growing confidence: ICICI Prudential Mutual Fund acquired approximately 21.82 lakh shares at ₹950 per share in December 2025, signalling institutional confidence at current levels. The acquisition was part of bulk deals, with a total transaction value of around ₹207.3 crores, showing significant institutional capital allocation. This institutional buying coincides with the technical support zone, suggesting smart money accumulation at perceived value levels. Sectoral Dynamics: India's Healthcare Distribution Opportunity: The Indian healthcare sector is experiencing transformative growth, valued at ₹31.87 lakh crores ($372 billion) in 2023 and projected to reach ₹54.67 lakh crores ($638 billion) by 2025, representing a 17.5-22.5% CAGR. Healthcare spending is increasing from 3.3% of GDP to an expected 5% by 2030, driven by government initiatives, insurance penetration, and rising middle-class healthcare consumption. Market Structure: The healthcare distribution sector in India remains highly fragmented, with consolidation opportunities. Entero's strategy of acquiring regional distributors aligns with this consolidation trend. Growth Drivers: - Expanding hospital infrastructure: Private hospitals adding 4,000+ beds with ₹11,500 crore investments in FY26 - Rising insurance penetration: Over 550 million Indians are now covered under health insurance schemes - Tier 2 and Tier 3 city expansion: 55-60% of new hospital beds coming from secondary cities - Ageing population: A Growing elderly demographic requiring chronic disease management - Medical tourism: Expected to reach $14.31 billion by 2029 Competitive Positioning: Strengths: - Pan-India presence with an extensive warehousing network - Authorised distributor for top pharmaceutical companies - Strategic relationships with leading corporate hospital chains - Technology-driven platform providing operational efficiency - Aggressive growth through acquisitions in a fragmented market Challenges: - Capital-intensive business model requiring continuous working capital - Thin margins are typical of distribution businesses - Integration risk from multiple acquisitions - Competition from established distributors and direct distribution by manufacturers Credit Rating and Financial Health: India Ratings affirmed Entero Healthcare's issuer rating at IND A-/Stable in December 2025, indicating adequate credit quality with a stable outlook. Working Capital Intensive: A Significant portion of IPO proceeds (₹600 crores) is allocated for long-term working capital requirements, highlighting the capital-intensive nature of the business. Strategic Outlook: The company is well-positioned to benefit from several macro trends: Healthcare Sector Consolidation: As the industry matures, organised distribution players like Entero will gain market share from fragmented local distributors. Digital Health Integration: The digital health market is expected to grow at a 24.4% CAGR from 2025-2030, and Entero's technology platform positions it to capitalise on this trend. Supply Chain Optimisation: Post-pandemic focus on resilient healthcare supply chains favours established distribution networks. Rural Penetration: Government push for rural healthcare infrastructure creates distribution opportunities beyond metros. Risk Factors: Business Risks: - High dependence on working capital financing - Potential for inventory obsolescence in pharmaceutical distribution - Regulatory changes in pharmaceutical pricing and distribution - Competition from direct-to-pharmacy models by manufacturers Financial Risks: - Debt levels from acquisition financing - Integration challenges from multiple acquisitions - Margin pressure in a competitive distribution landscape Key Metrics to Watch: - EBITDA margin improvement from operational leverage - Return on capital employed as brownfield expansions mature - Working capital efficiency and cash conversion cycle - Market share gains in key geographies My 2 Cents: Entero Healthcare is at a critical technical juncture, testing the boundaries of a months-long downtrend. The stock has established a strong support base around ₹944-1,000, coinciding with IPO pricing memories and significant institutional buying. Recent volume surge and price action suggest potential trend reversal, though confirmation requires a sustained break above ₹1,200. The technical setup presents a balanced risk-reward for traders willing to use tight stops below ₹944, with initial upside targets of ₹1,300-1,400 if the reversal confirms. From a fundamental perspective, Entero Healthcare operates in a structurally attractive sector with strong tailwinds. The company has demonstrated impressive revenue growth and recently achieved profitability. Its extensive distribution network and strategic acquisitions position it well for continued market share gains in a consolidating industry. However, investors should note the capital-intensive nature of the business, integration risks from rapid acquisitions, and the need for sustained margin improvement to justify valuations. The alignment of technical support with institutional buying at ₹950 levels and the strong sectoral backdrop creates an interesting setup. The stock appears to be transitioning from the IPO distribution phase to the potential accumulation phase. For position traders, the current levels offer an entry opportunity with defined risk below ₹944 and potential reward toward ₹1,300-1,400. The key catalysts to watch include: - Quarterly results demonstrating margin expansion - Successful integration of recent acquisitions - Sustained volume above ₹1,200 confirming trend reversal - Further institutional accumulation - Sector-wide tailwinds from healthcare spending growth The convergence of technical base formation, institutional interest, and strong sectoral dynamics creates a compelling narrative, though investors should remain mindful of execution risks and maintain appropriate position sizing with stop losses. Full Coverage on my Mid-Week Newsletter coming Wednesday. Keep in the Watchlist and DOYR. NO RECO. For Buy/Sell. 📌Thank you for exploring my idea! I hope you found it valuable. 🙏FOLLOW for more 👍BOOST if you found it useful. ✍️COMMENT below with your views. Meanwhile, check out my other stock ideas on the right side until this trade is activated. I would love your feedback. As per the Latest SEBI Mandate, this isn't a Trading/Investment RECOMMENDATION nor for Educational Purposes; it is just for Informational purposes only. The chart data used is 3 Months old, as Showing Live Chart Data is not allowed according to the New SEBI Mandate. Disclaimer: "I am not a SEBI REGISTERED RESEARCH ANALYST AND INVESTMENT ADVISER." This analysis is intended solely for informational purposes and should not be interpreted as financial advice. It is advisable to consult a qualified financial advisor or conduct thorough research before making investment decisions.
NSE:ENTEROLong
by Karanshah137
10
IREDA – Neo Wave Time-Based Impulse SetupThe prior impulse completed in approximately 155 bars, followed by a corrective phase that has already consumed around 367 bars, resulting in a time ratio of about 2.36, which confirms a complex correction under Neo Wave time rules rather than a trend reversal. The corrective structure is interpreted as a W–X–Y–X–Z combination, supported by overlapping price action, contracting volatility, and declining momentum. Two corrective trendlines are drawn to control directional bias: trendline 1 marks the broader corrective resistance, and trendline 2 represents the internal corrective structure. A new impulse will be considered valid only after price decisively breaks and closes above trendline 2, which would confirm the start of impulse wave 1. No entry is planned on the breakout itself; the focus is on waiting for a corrective pullback that holds above 50 percent of the last X-wave, qualifying this retracement as corrective wave 2. A long entry will be considered only after wave 2 is complete and price breaks the internal pullback structure, signaling the beginning of impulse wave 3. Any failure to break trendline 2, or any move back below 50 percent of wave X, keeps the structure corrective and invalidates the bullish impulse scenario. This setup is based on Neo Wave time exhaustion and structural confirmation, with the objective of participating in wave 3 rather than predicting the market bottom.
NSE:IREDALong
by krusaabhrajput
3
IIFL Capital (W): Aggressive Bullish (Re-rating Breakout)Timeframe: Weekly | Scale: Logarithmic The stock has confirmed a major breakout from an 8-month consolidation pattern. This move is not just a technical fluctuation; it represents a structural "Re-rating" of the business following its pivot from pure broking to broader capital services. 🚀 1. The Fundamental Catalyst (The "Why") The surge is driven by a convergence of business transformation and sector strength: > Strategic Rebranding: The name change to "Capital Services" signals a shift towards high-margin Wealth Management and Distribution. The market is finally pricing in this higher valuation multiple, which explains the sudden volume spike. > Sector Tailwind: The entire capital market ecosystem (BSE, CDSL, Angel One) has been rallying in Dec 2025/Jan 2026 due to renewed retail participation, providing a "Sectoral Lift" to the stock. 📈 2. The Chart Structure (The Box Breakout) > The Setup: A Rectangular Pattern (Sideways Trend) that trapped the stock between May 2025 and last week. > Resistance: The confluence of the Angular Resistance (from the Oct 2024 ATH) and the Horizontal Box Top was a formidable barrier. > The Breakout: This week’s surge of 16.17% is a decisive "Marubozu-style" candle . It smashed through both resistance layers in a single move, confirming that the correction from Apr 2025 is officially over. 📊 3. Volume & Indicators > Volume Ignition: The 9.61 Million weekly volume is an "Institutional Stamp." Such high volume after a quiet consolidation indicates that large funds are entering to ride the new leg up. > Momentum: - RSI: Rising in Monthly & Weekly timeframes confirms that momentum is synchronized with price. - EMAs: The Positive Crossover confirms the trend has shifted from "Sideways" to "Markup." 🎯 4. Future Scenarios & Key Levels The stock is now in a "Markup Phase" heading toward its previous peaks. > 🐂 Bullish Targets (The Recovery): - Target 1: 425. This is a major structural hurdle. - Target 2: 449 (ATH) . Once 425 is cleared, the path to the All-Time High of 448.95 (Oct 2024) is technically open. > 🛡️ Support (The "Must Hold"): - Immediate Support: 352 . This is the breakout zone. The "Polarity Principle" dictates that this previous ceiling must now act as a floor. - Stop Loss: A weekly close below 340 would imply the breakout was a "Bull Trap" and invalidation of the setup. Conclusion This is a Grade A Setup . > Confirmation: The combination of High Volume + Pattern Breakout + Fundamental Rebranding makes this a high-probability trade. > Strategy: Use dips to the 352-360 zone to enter/add, targeting 425 and eventually the ATH of 449 .
NSE:IIFLCAPSLong
by Learn_with_Pth0mas
RVNL Can Give 20–30% Upside Move🚀 One Stock That Can Give 20–30% Upside Move Stock: RVNL Limited 🚆 - NSE:RVNL 🔥 Why This Stock Is On The Radar • Railways capex cycle remains strong with execution visibility • Order inflow momentum continues to support earnings outlook • PSU rail stocks remain leadership names in the current market This Is Not A Fresh Breakout. This Is A Re-accumulation Setup At Higher Levels. 📊 What The Chart Is Showing • Strong rally already played out earlier • Price has shifted into time correction, not price correction • No major breakdown despite volatility That Is The Key Observation. 📈 Current Price Behaviour • Price consolidating around the 355–370 zone • Candles overlapping tightly • Volatility compression visible • Higher lows still intact Price Is Holding Strength. It Is Not Distributing. ⏳ Why A 20–30% Move Is Possible • Rail stocks typically move in momentum legs • Supply has been absorbed during consolidation • Breakout from a tight range can be swift 🎯 Trade Idea Framework • Entry: Sustained hold above 372 • Stop-Loss: Below 345 • Targets: – Target 1: 430 – Target 2: 480 👀 Confirmation Rule • After breakout, price should not fall back below 365 • Volume should expand on the breakout Back Below The Range = No Trade. Hold Above The Range = Momentum Active. 🧠 Final Line Strong Moves Often Resume After Quiet Consolidation. RVNL Is Currently In That Phase. That Is The Edge.
NSE:RVNLLong
by Trendxinc
XAUUSD (D1) – Elliott ABC pattern activeLana sells the pullback, waits to buy at major liquidity 💛 Quick summary Timeframe: Daily (D1) Elliott view: Price is likely developing an ABC corrective structure after a strong rally Strategy: Sell the B-wave pullback into supply, buy only when price returns to strong liquidity Context: Precious metals started 2026 strong, but short-term volatility and re-accumulation swings are still expected Fundamental backdrop (supports the bigger trend) Gold and silver opened 2026 with strong momentum, extending the best run since the late 1970s. Goldman Sachs remains bullish on precious metals and continues to highlight an aggressive long-term target (around $4,900 for gold). Lana’s key point: the long-term bull cycle can remain intact, but the market still needs healthy corrections to reset liquidity and build new structure. Technical view (D1) – Elliott ABC structure On the Daily chart, after the powerful top, gold dropped sharply, forming a clean Wave A. The current structure suggests: Wave B: a corrective rebound into resistance/supply Wave C: a potential move back down into liquidity zones before the next major direction is confirmed This ABC lens helps avoid getting trapped when the news looks bullish, but price is still in a corrective phase. Key levels from the chart 1) Sell zone (B-wave supply) Sell: 4435 – 4440 This zone aligns with marked resistance and a Fibonacci pullback cluster (0.236 / 0.382). If price retraces here and shows rejection, it’s a strong area to look for B-wave selling pressure. 2) Buy zone (major liquidity – potential C-wave completion) Buy Liquidity: 4196 – 4200 This is the strongest liquidity area on the chart. If Wave C plays out, Lana will look for buying opportunities here with clearer risk control. 3) Deeper accumulation liquidity Accumulate liquidity: the lower accumulation area highlighted on the chart If the market sweeps deeper than expected, this is the region where longer-term buyers may step in. Trading plan (Lana’s approach) Primary idea: Sell rallies into 4435–4440 if price shows weakness (B-wave rejection). Primary buy plan: Wait for price to revisit 4196–4200 and confirm support (liquidity absorption). If price breaks and holds above the sell zone, Lana stops selling and waits for a new structure to form. Note on early-year behavior The first weeks of the year often bring “messy” moves as liquidity returns and positioning resets. Lana will only trade at planned zones and avoid entries in the middle of the range. This is Lana’s personal market view and not financial advice.
OANDA:XAUUSDShort
by Lana_M2
2